Capelle aan den IJssel, the Netherlands - 7 July 2017 - On the Extraordinary General Meeting of Shareholders held today Sean Fernback and Kees Molenaar have been appointed by the shareholders as members of the Supervisory Board of AND.
End of May AND announced to expand the Supervisory Board to five members and to nominate today Sean Fernback and Kees Molenaar for appointment as new members of the Supervisory Board. On 24 May, Sean and Kees were formally nominated and today the appointments are formalized. They are appointed for a period of four years.
Rob Westerhof, chairman of the AND Supervisory Board: "I am delighted with the announcement of these nominations. Sean Fernback, former CEO of HERE, is a true industry expert and brings a wealth of experience and in-depth knowledge of the mapping, navigation and location spaces. Kees Molenaar has a broad experience in advisory boards and is very familiar with the Dutch corporate governance model. I am certain that they will be of great benefit to the functioning of the Supervisory Board."
This is an English translation of the Dutch press release. In the event of any disparity between the Dutch original and this translation, the Dutch text will prevail.
Note for editor, not for publication.
For further information, please contact Hugo van der Linde on 0031-10-8851200 or go to www.and.com


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



